bioMerieux, Inc. Issues Urgent Expanded Product Recall for VITEK® 2 Piperacillin/Tazobactam Test on Gram Negative Susceptibility (BMXMF)

As a follow up to the communication issued on September 16, 2010, bioMerieux (

) is voluntarily expanding its worldwide product recall of VITEK ^® 2 Gram Negative Susceptibility Cards containing the antibiotic Piperacillin/Tazobactam (TZP2). These cards, manufactured after March 10, 2009, are used in clinical laboratories to perform antimicrobial susceptibility testing as part of the VITEK ^® 2 System. Clinical laboratories have been notified to perform an alternative method of testing prior to reporting results for: * Piperacillin/Tazobactam (TZP2) and Escherichia coli, Morganella morganii, Proteus mirabilis, Proteus vulgaris, Providencia rettgeri, Providencia stuartii, Pseudomonas aeruginosa and Salmonella enterica * Piperacillin/Tazobactam (TZP2) and Klebsiella pneumoniae with resistant results